Overview
- Editors:
-
-
Walter Weber
-
Swiss Cancer League, Bern, Switzerland
Access this book
Other ways to access
Table of contents (27 papers)
-
Front Matter
Pages I-XIII
-
-
Introduction to the Seminar
-
-
Aetiology and Epidemiology
-
-
- Martin Gebhardt, Mauro Buser, Walter Weber, Susanna Mosimann, Joachim Torhorst, Hansjakob Müller
Pages 7-11
-
- Rodney J. Scott, Martina Spycher, Walter Weber, Hansjakob Müller
Pages 13-15
-
- S. Ashraf Imam, Laura A. Mills, Sen Pathak, Clive R. Taylor
Pages 17-21
-
-
-
- Monica Castiglione-Gertsch
Pages 31-34
-
-
Lynch Syndromes
-
-
- Henry T. Lynch, Jane F. Lynch, Giuseppe Cristofaro
Pages 39-43
-
- Giuseppe Cristofaro, Eupremio Carrozzo, Frederick Gentile, Emilio Di Giulio
Pages 45-49
-
Treatment
-
-
-
- Markus Zuber, Urban Laffer, Felix Harder
Pages 59-64
-
- S. Martinoli, L. Mariani, A. Goldhirsch
Pages 65-68
-
-
About this book
The European School of Oncology came into existence to respond to a need for informa tion, education and training in the field of the diagnosis and treatment of cancer. There are two main reasons why such an initiative was considered necessary. Firstly, the teaching of oncology requires a rigorously multidisciplinary approach which is difficult for the Univer sities to put into practice since their system is mainly disciplinary orientated. Secondly, the rate of technological development that impinges on the diagnosis and treatment of cancer has been so rapid that it is not an easy task for medical faculties to adapt their curricula flexibly. With its residential courses for organ pathologies and the seminars on new techniques (laser, monoclonal antibodies, imaging techniques etc.) or on the principal therapeutic controversies (conservative or mutilating surgery, primary or adjuvant chemotherapy, radiotherapy alone or integrated), it is the ambition of the European School of Oncology to fill a cultural and scientific gap and, thereby, create a bridge between the University and Industry and between these two and daily medical practice. One of the more recent initiatives of ESO has been the institution of permanent study groups, also called task forces, where a limited number of leading experts are invited to meet once a year with the aim of defining the state of the art and possibly reaching a consensus on future developments in specific fields of oncology.
Editors and Affiliations
-
Swiss Cancer League, Bern, Switzerland
Walter Weber